Phathom Pharmaceuticals, Inc.盘中异动早盘快速拉升5.08%_老虎社区_美港股上老虎

Phathom Pharmaceuticals, Inc.盘中异动早盘快速拉升5.08%

市场透视2025-07-08

北京时间2025年07月08日22时39分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现异动，股价大幅拉升5.08%。截至发稿，该股报9.10美元/股，成交量13.6345万股，换手率0.20%，振幅5.02%。最近的财报数据显示，该股实现营业收入28.52百万美元，净利润-94.32百万美元，每股收益-1.31美元，毛利24.80百万美元，市盈率-1.75...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2549267735?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-08 22:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2549267735","market":"us","top_or_hot":-1,"title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.08%","media":"市场透视","content":"<div>\n<p>北京时间2025年07月08日22时39分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现异动，股价大幅拉升5.08%。截至发稿，该股报9.10美元/股，成交量13.6345万股，换手率0.20%，振幅5.02%。最近的财报数据显示，该股实现营业收入28.52百万美元，净利润-94.32百万美元，每股收益-1.31美元，毛利24.80百万美元，市盈率-1.75...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223950979e7264&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Phathom Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.08%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhathom Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.08%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-08 22:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223950979e7264&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年07月08日22时39分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现异动，股价大幅拉升5.08%。截至发稿，该股报9.10美元/股，成交量13.6345万股，换手率0.20%，振幅5.02%。最近的财报数据显示，该股实现营业收入28.52百万美元，净利润-94.32百万美元，每股收益-1.31美元，毛利24.80百万美元，市盈率-1.75...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223950979e7264&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHAT","symbol_name":"Phathom Pharmaceuticals","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223950979e7264&s=b","article_id":"2549267735","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223950979e7264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2549267735","pubTimestamp":1751985590,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年07月08日22时39分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.08%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Moleculin Biotech, Inc.、Seastar Medical Holding Corporation、Rallybio Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为893.94%、465.69%、266.73%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Moleculin Biotech, Inc.、Rallybio Corporation，振幅分别为70.96%、69.44%、59.87%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PHAT":"Phathom Pharmaceuticals","BK4007":"制药"},"translate_title":"Phathom Pharmaceuticals, Inc. quickly rose 5.08% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHAT":1},"content_text":"北京时间2025年07月08日22时39分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现异动，股价大幅拉升5.08%。截至发稿，该股报9.10美元/股，成交量13.6345万股，换手率0.20%，振幅5.02%。最近的财报数据显示，该股实现营业收入28.52百万美元，净利润-94.32百万美元，每股收益-1.31美元，毛利24.80百万美元，市盈率-1.75倍。机构评级方面，在所有9家参与评级的机构中，89%的券商给予买入建议，11%的券商给予持有建议，无券商给予卖出建议。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Moleculin Biotech, Inc.、Seastar Medical Holding Corporation、Rallybio Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为893.94%、465.69%、266.73%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Moleculin Biotech, Inc.、Rallybio Corporation，振幅分别为70.96%、69.44%、59.87%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。 该公司专注于开发和商业化胃肠道疾病的新型疗法。 它的产品由vonoprazan（一种口服的小分子钾竞争性酸阻滞剂）组成，可阻断胃酸的分泌。 Vonoprazan具有快速， 有效和持久的抗分泌作用，并已证明在治疗胃食管反流疾病以及与抗生素联合治疗幽门螺杆菌感染方面具有临床效益。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}